Pmv Pharmaceuticals Inc (PMVP NASDAQ) stock market data APIs
$1.37
-0.05(-3.6%)
as of November 2, 2026
Try our APIs with
free plan!
Pmv Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Prev. Close
1.37
Open
1.3183
High
1.4079
Low
1.3096
52 wk Range
1.02-1.91
Market Cap
103 M
Shares Outstanding
75 513 K
EPS
-0.34
Beta
1.513
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pmv Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pmv Pharmaceuticals Inc data using free add-ons & libraries
Get Pmv Pharmaceuticals Inc Fundamental Data
Pmv Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -79 543 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -0.38
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pmv Pharmaceuticals Inc News
New
PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know
PMV Pharmaceuticals PMVP has gained nearly 19% in the past three months, primarily due to encouraging clinical data for its lead drug candidate, rezatapopt, and progress toward a potential regulatory ...
These Biotech Stocks Are Cheap Based On 1 Fundamental Measure
With the Federal Reserve lifting interest rates for the first time in more than three years and signalling that money will not be cheap again quickly, investors are being pushed to think harder about ...
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
PMV Pharmaceuticals, Inc. Commercial leadership appointment supports launch preparation for rezatapopt Company planning NDA submission for accelerated approval of rezatapopt in patients with platinu...
PMV Pharma prices $50M IPO at $1.21 per share
[IPO Initial Public Offering] * PMV Pharmaceuticals (PMVP [https://seekingalpha.com/symbol/PMVP]) priced [https://seekingalpha.com/pr/20635412-pmv-pharma-announces-pricing-of-oversubscribed-50-mill...
Get Pmv Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.